We are live on ! Find out more
NTUS

Natus Medical Inc

Delisted

NTUS was delisted on the 20th of July, 2022.

214 hedge funds and large institutions have $1.22B invested in Natus Medical Inc in 2017 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 54 increasing their positions, 89 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

76% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 21

56% more call options, than puts

Call options by funds: $5.78M | Put options by funds: $3.71M

8% more funds holding

Funds holding: 198214 (+16)

3% more capital invested

Capital invested by funds: $1.18B → $1.22B (+$35.2M)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

39% less repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 89

Holders
214
Holders Change
+16
Holders Change %
+8.08%
% of All Funds
4.85%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
37
Increased
54
Reduced
89
Closed
21
Calls
$5.78M
Puts
$3.71M
Net Calls
+$2.07M
Net Calls Change
+$8.92M
Name Holding Trade Value Shares
Change
Change in
Stake
CSS
151
Cubist Systematic Strategies
Connecticut
$224K +$234K +5,856 New
FCAG
152
First Capital Advisors Group
New Jersey
$222K +$232K +5,811 New
AF
153
Allworth Financial
California
$221K
FA
154
FDx Advisors
Illinois
$220K -$798 -20 -0.3%
GCA
155
Greenwood Capital Associates
South Carolina
$219K +$229K +5,734 New
JG
156
Jefferies Group
New York
$213K -$325K -8,139 -59%
ProShare Advisors
157
ProShare Advisors
Maryland
$209K +$219K +5,479 New
FCM
158
Flinton Capital Management
Pennsylvania
$197K +$31.2K +782 +18%
Parallax Volatility Advisers
159
Parallax Volatility Advisers
California
$176K +$184K +4,620 New
Envestnet Asset Management
160
Envestnet Asset Management
Illinois
$166K +$10.6K +266 +7%
TAM
161
Tyers Asset Management
Texas
$163K +$25.7K +644 +18%
RCM
162
Riverhead Capital Management
Delaware
$147K +$24K +600 +19%
NA
163
Neuburgh Advisers
California
$128K +$20.2K +506 +18%
SFSIG
164
San Francisco Sentry Investment Group
California
$125K -$75.5K -1,890 -37%
AIP
165
Ameritas Investment Partners
Nebraska
$107K
PNC Financial Services Group
166
PNC Financial Services Group
Pennsylvania
$105K -$4.67K -117 -4%
US Bancorp
167
US Bancorp
Minnesota
$100K -$1.44K -36 -1%
BFEC
168
Benjamin F. Edwards & Company
Missouri
$94K -$10.7K -268 -10%
MCIM
169
Meadow Creek Investment Management
Georgia
$93K +$14.7K +368 +18%
PCM
170
Prelude Capital Management
New York
$84K -$6.91K -173 -7%
ZB
171
Zions Bancorporation
Utah
$73K +$75.9K +1,902 New
Zurich Cantonal Bank
172
Zurich Cantonal Bank
Switzerland
$63K +$31.7K +795 +93%
Federated Hermes
173
Federated Hermes
Pennsylvania
$58K -$1.04K -26 -2%
MOACM
174
Mutual of America Capital Management
New York
$55K
II
175
Inspire Investing
Idaho
$55K +$57.3K +1,435 New

NTUS Hedge Fund Activity: Q4 2017 in Review

214 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q4 2017, worth a combined $1.22B — up 3% from $1.18B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new NTUS positions and 21 closed out — a net gain of 16 holders — while 54 added to existing stakes and 89 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $67.6M. The largest seller was Epoch Investment Partners, exiting entirely with an estimated $20.8M sold.

  • 214 institutional investors held Natus Medical Inc (NTUS) as of Q4 2017, up from 198 in Q3 2017.
  • Funds reported $1.22B of Natus Medical Inc stock for Q4 2017, up 3% quarter-over-quarter.
  • 37 funds opened new Natus Medical Inc positions in Q4 2017 and 21 closed out, a net change of +16 holders.
  • The largest Natus Medical Inc buyer in Q4 2017 was Janus Henderson Group, an estimated $67.6M added.
  • The largest Natus Medical Inc seller in Q4 2017 was Epoch Investment Partners, an estimated $20.8M sold.

Based on aggregated 13F filings for Q4 2017.